Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
AOCI, Bushey, carryforward, clarified, consulting, Deputy, exclusive, exclusivity, forfeiture, Hamilton, headcount, immaterial, LP, macroeconomic, marketplace, merit, nonrefundable, Overnight, Paproski, Pepper, quickly, Rachael, remitted, SelfDose, SSAR, stringent, team, therapeutic, tranche, unearned
Removed:
bank, conform, converting, define, developer, difficulty, effort, exclude, forma, implementing, initial, intent, Ireland, La, main, Medimop, month, move, noncontrolling, outlook, pretax, pro, qualification, recovery, relocation, remained, Republic, resin, resolution, rigid, saving, unused, USD
Filing tables
Filing exhibits
- 10-K Annual report
- 10.16 Exhibit 10.16 Change-in-control Agreement
- 10.17 Exhibit 10.17 Change-in-control Agreement
- 10.18 Exhibit 10.18 Change-in-control Agreement
- 10.26 Exhibit 10.26 Non-qualified Deferred Compensation Plan
- 12.1 Exhibit 12.1 Ratio of Earnings to Fixed Charges
- 21 Exhibit 21 Subsidiaries
- 23 Exhibit 23 Consent of Independent Registered Public Accounting Firm
- 24 Exhibit 24 Powers of Attorney
- 31.1 Exhibit 31.1 CEO Section 302 Certification
- 31.2 Exhibit 31.2 CFO Section 302 Certification
- 32.1 Exhibit 32.1 CEO Section 906 Certification
- 32.2 Exhibit 32.2 CFO Section 906 Certification
- Download Excel data file
- View Excel data file
Related press release
WST similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-3 (Registration Nos. 333-88358, 333-128438, 333-133863 and 333-145186) and Forms S-8 (Registration Nos. 333-106977, 333-115175, 333-143129, 333-143437, 333-156492 and 333-174153) of West Pharmaceutical Services, Inc. of our report dated February 27, 2014 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 27, 2014